Importantly, in the absence of an adaptive immune response, the inhibition of CXCR2+ cell recruitment to the tumor exhibited a nonsignificant trend toward reduced tumor growth, suggesting that the loss of CXCR2+ cell recruitment was not sufficient to rescue MEKi-induced tumor suppression (data not shown). The gene discussed is CXCR2; the disease is neoplasm.